These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 21826023)
21. Mineralocorticoid receptor activation in obesity hypertension. Nagase M; Fujita T Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418 [TBL] [Abstract][Full Text] [Related]
22. Immune system alterations by aldosterone during hypertension: from clinical observations to genomic and non-genomic mechanisms leading to vascular damage. Muñoz-Durango N; Barake MF; Letelier NA; Campino C; Fardella CE; Kalergis AM Curr Mol Med; 2013 Jul; 13(6):1035-46. PubMed ID: 23590758 [TBL] [Abstract][Full Text] [Related]
23. Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockade. Del Vecchio L; Procaccio M; Viganò S; Cusi D Nat Clin Pract Nephrol; 2007 Jan; 3(1):42-9. PubMed ID: 17183261 [TBL] [Abstract][Full Text] [Related]
24. Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells. Rautureau Y; Paradis P; Schiffrin EL Steroids; 2011 Aug; 76(9):834-9. PubMed ID: 21371487 [TBL] [Abstract][Full Text] [Related]
25. Aldosteronism revisited: perspectives on less well-recognized actions of aldosterone. Weber KT J Lab Clin Med; 2003 Aug; 142(2):71-82. PubMed ID: 12960953 [TBL] [Abstract][Full Text] [Related]
31. Mineralocorticoids and cardiovascular diseases. Status of knowledge from experimental and clinical studies. Pasquale PD; Stefano GD; Paterna S Ital Heart J; 2000 Sep; 1(9):595-604. PubMed ID: 11130838 [TBL] [Abstract][Full Text] [Related]
32. Toll-like receptors and immune regulation: implications for cancer therapy. Wang RF; Miyahara Y; Wang HY Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599 [TBL] [Abstract][Full Text] [Related]
33. Regulatory T cells in health and disease. Piccirillo CA Cytokine; 2008 Sep; 43(3):395-401. PubMed ID: 18722786 [TBL] [Abstract][Full Text] [Related]
34. Responses Triggered by the Immune System in Hypertensive Conditions and Repercussions on Target Organ Damage: A Review. da Silva CHND; Guedes IHL; de Lima JCS; Sobrinho JMDR; Dos Santos AA Curr Cardiol Rev; 2023; 19(2):e200922208959. PubMed ID: 36125837 [TBL] [Abstract][Full Text] [Related]
35. Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? Catena C; Colussi GL; Brosolo G; Bertin N; Novello M; Palomba A; Sechi LA Int J Endocrinol; 2017; 2017():4397028. PubMed ID: 29056965 [TBL] [Abstract][Full Text] [Related]
36. New frontiers in aldosterone/mineralocorticoid biology: a reemerging force in target organ damage and hypertension. Kurtz TW; Catanzaro DF Am J Hypertens; 2001 Dec; 14(12):1276-7. PubMed ID: 11775139 [No Abstract] [Full Text] [Related]
37. The immunology of hypertension. Norlander AE; Madhur MS; Harrison DG J Exp Med; 2018 Jan; 215(1):21-33. PubMed ID: 29247045 [TBL] [Abstract][Full Text] [Related]
39. Hormonal control of trained immunity: aldosterone at the crossroad between activation of innate immunity and cardiovascular diseases. Matarese G; Norata GD Cardiovasc Res; 2020 Feb; 116(2):256-257. PubMed ID: 31346597 [No Abstract] [Full Text] [Related]